oculocutaneous albinism

ICD-10 Codes

Related ICD-10:

Description

What is Oculocutaneous Albinism?

Oculocutaneous albinism (OCA) is a rare inherited disorder characterized by a reduction or complete lack of melanin pigment in the skin, hair, and eyes [1]. This condition affects the production of melanin, which is responsible for skin, hair, and eye pigmentation.

Symptoms of Oculocutaneous Albinism

People with oculocutaneous albinism have extremely pale skin, eyes, and hair due to the lack of melanin production [8]. The condition can also cause vision problems, including sensitivity to light and blurred vision. In severe cases, it can lead to complete absence of melanin, resulting in white hair and skin [9].

Types of Oculocutaneous Albinism

There are several types of oculocutaneous albinism, with the most common type being inherited from both parents [4]. Other types include ocular albinism (OA), which mainly affects the eyes, and a severe form of OCA1 characterized by complete absence of melanism [7].

Causes and Inheritance

Oculocutaneous albinism is caused by mutations in genes responsible for melanin production. It is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition [4].

References:

  • [1] Mar 17, 2023 — Oculocutaneous albinism is a group of conditions that affect coloring (pigmentation) of the skin, hair, and eyes.
  • [2] Oculocutaneous albinism (OCA) is a group of rare inherited disorders characterized by a reduction or complete lack of melanin pigment in the skin, hair and eyes ...
  • [4] Dec 13, 2023 — Types of albinism · Oculocutaneous albinism (OCA), the most common type, means a person gets two copies of a changed gene — one from each parent.
  • [7] oculocutaneous albinism (OCA) – the most common type, affecting the skin, hair and eyes; ocular albinism (OA) – a rarer type that mainly affects the eyes ...
  • [8] Albinism is a rare genetic condition that affects the amount of melanin your body produces. People with albinism have extremely pale skin, eyes and hair.
  • [9] A severe form of oculocutaneous albinism type 1 (OCA1) characterized by complete absence of melanin and manifesting as white hair and skin.

Additional Characteristics

  • a rare inherited disorder
  • characterized by a reduction or complete lack of melanin pigment in the skin, hair, and eyes
  • caused by mutations in genes responsible for melanin production
  • inherited in an autosomal recessive pattern
  • resulting in white hair and skin

Signs and Symptoms

Symptoms of Oculocutaneous Albinism

Oculocutaneous albinism (OCA) is a group of conditions that affect the coloring (

Additional Symptoms

  • Increased sensitivity to light
  • Vision loss or blindness
  • Pale skin and hair
  • Vision difficulties, such as seeing only in shades of gray

Diagnostic Tests

Diagnosing Oculocutaneous Albinism: A Comprehensive Overview

Oculocutaneous albinism (OCA) is a group of rare genetic disorders that affect the production of melanin, leading to varying degrees of skin, hair, and eye hypopigmentation. Accurate diagnosis is crucial for providing appropriate care and management. Here's an overview of the diagnostic tests used to diagnose

Additional Diagnostic Tests

  • Skin biopsy
  • Wood's Lamp examination
  • Hair examination
  • Eye examination

Treatment

Current Treatment Options for Oculocutaneous Albinism

Oculocutaneous albinism, a genetic disorder affecting the production of melanin, currently has no cure. However, treatment focuses on managing symptoms and improving quality of life.

  • Eye Care: Regular eye exams are essential to monitor and manage potential eye problems associated with albinism, such as vision loss or blindness.
  • Skin Monitoring: Skin care is crucial to prevent skin problems, including sun damage and skin cancer.
  • Newer Treatments: Research suggests that newer treatments, such as l-dihydroxyphenylalanine (L-DOPA) and nitisinone, may be explored for their potential in raising melanin levels and slightly darkening hair. However, these are still in the experimental stages [4][6].

FDA-Approved Drugs

While there is no specific FDA-approved treatment for oculocutaneous albinism, some drugs have been approved for related conditions:

  • Nitisinone (NTBC): An FDA-approved drug used to treat hereditary tyrosinemia type 1, which also affects melanin production [3][5].
  • L-DOPA: A precursor to dopamine and norepinephrine, L-DOPA has been studied for its potential in treating albinism-related conditions.

Challenges and Future Directions

Despite ongoing research, there is currently no effective treatment or cure for oculocutaneous albinism. However, exploring newer treatments and improving quality of life through symptom management remains a priority [9].

References:

[1] Context result 2 [3] Context result 5 [4] Context result 6 [5] Context result 7 [6] Context result 8

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Oculocutaneous Albinism

Oculocutaneous albinism (OCA) is a rare inherited disorder characterized by reduced or complete lack of melanin pigment in the skin, hair, and eyes. When diagnosing OCA, it's essential to consider differential diagnoses that may present similar symptoms.

Key Differential Diagnoses:

  • Hermansky-Pudlak Syndrome (HPS): A genetic disorder affecting melanosome formation, leading to albinism-like symptoms.
  • Albinoidism: A rare condition characterized by reduced pigmentation in the skin and hair, often associated with ocular abnormalities.
  • Waardenburg Syndrome (WS): A genetic disorder affecting melanocyte development, resulting in hearing loss, eye abnormalities, and albinism-like symptoms.
  • Chediak-Higashi Syndrome (CHS): A rare genetic disorder affecting melanosome formation, leading to albinism-like symptoms and immune system dysfunction.
  • Griscelli Syndrome: A rare genetic disorder affecting melanosome formation, resulting in albinism-like symptoms and immune system dysfunction.

Key Features of Differential Diagnoses:

  • HPS: Characterized by oculocutaneous albinism, platelet dysfunction, and pulmonary fibrosis [4].
  • Albinoidism: Presents with reduced pigmentation in the skin and hair, often associated with ocular abnormalities [5].
  • WS: Affects melanocyte development, resulting in hearing loss, eye abnormalities, and albinism-like symptoms [6].
  • CHS: Characterized by albinism-like symptoms, immune system dysfunction, and bleeding disorders [9].
  • Griscelli Syndrome: Presents with albinism-like symptoms, immune system dysfunction, and platelet dysfunction [14].

References:

[4] Hermansky-Pudlak syndrome. (2024, Sep 2). Retrieved from (Result 4) [5] Albinoidism. (2007). Retrieved from (Result 6) [6] Waardenburg Syndrome. (2024, Oct 22). Retrieved from (Result 7) [9] Oculocutaneous albinism and ocular albinism must be differentiated from the following rare disease: Hermansky-Pudlak syndrome, Chediak-Higashi syndrome, ... (2021, Aug 23). Retrieved from (Result 9) [14] Griscelli Syndrome. (2024, Oct 22). Retrieved from (Result 14)

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
Xref MGI. OMIM mapping confirmed by DO. [SN].
oboInOwl#id
DOID:0050632
core#notation
DOID:0050632
oboInOwl#hasDbXref
ORDO:55
IAO_0000115
A syndrome characterized by abnormal pigmentation of the skin, hair and eyes.
rdf-schema#label
oculocutaneous albinism
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0080614
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
relatedICD
http://example.org/icd10/E70.3
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_669
owl#annotatedSource
t332276

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.